WO2009026133A3 - Transdermal bisoprolol delivery system - Google Patents
Transdermal bisoprolol delivery system Download PDFInfo
- Publication number
- WO2009026133A3 WO2009026133A3 PCT/US2008/073270 US2008073270W WO2009026133A3 WO 2009026133 A3 WO2009026133 A3 WO 2009026133A3 US 2008073270 W US2008073270 W US 2008073270W WO 2009026133 A3 WO2009026133 A3 WO 2009026133A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bisoprolol
- transdermal
- delivery system
- delivery
- rate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Abstract
A transdermal bisoprolol delivery system to an individual in need thereof. The system includes a backing layer, a reservoir disposed proximally relative to the backing layer. The reservoir has a polymeric composition containing an amount of bisoprolol or a pharmaceutically acceptable salt thereof sufficient for multiple-day delivery. The system can have a rate-control layer to control the rate of bisoprolol delivery to the user.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96507907P | 2007-08-17 | 2007-08-17 | |
US60/965,079 | 2007-08-17 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009026133A2 WO2009026133A2 (en) | 2009-02-26 |
WO2009026133A3 true WO2009026133A3 (en) | 2010-04-01 |
Family
ID=39769545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/073270 WO2009026133A2 (en) | 2007-08-17 | 2008-08-15 | Transdermal bisoprolol delivery system |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009026133A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8512742B2 (en) | 2009-05-01 | 2013-08-20 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal preparation |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005042055A2 (en) * | 2003-10-28 | 2005-05-12 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device |
US20060078604A1 (en) * | 2004-10-08 | 2006-04-13 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
WO2006080199A1 (en) * | 2005-01-31 | 2006-08-03 | Hisamitsu Pharmaceutical Co., Inc. | Patch |
WO2007029781A1 (en) * | 2005-09-09 | 2007-03-15 | Nitto Denko Corporation | Adhesive preparation containing bisoprolol |
WO2007035939A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | High enhancer-loading polyacrylate formulation for transdermal applications |
WO2007065303A1 (en) * | 2005-12-09 | 2007-06-14 | Beijing Kangbeide Pharmaceutical Technology Development Co., Ltd. | Transdermal patch containing isosorbide dinitrate and bisoprolol |
-
2008
- 2008-08-15 WO PCT/US2008/073270 patent/WO2009026133A2/en active Application Filing
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005042055A2 (en) * | 2003-10-28 | 2005-05-12 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device |
US20060078604A1 (en) * | 2004-10-08 | 2006-04-13 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery device including an occlusive backing |
WO2006080199A1 (en) * | 2005-01-31 | 2006-08-03 | Hisamitsu Pharmaceutical Co., Inc. | Patch |
EP1847264A1 (en) * | 2005-01-31 | 2007-10-24 | Hisamitsu Pharmaceutical Co. Inc. | Patch |
WO2007029781A1 (en) * | 2005-09-09 | 2007-03-15 | Nitto Denko Corporation | Adhesive preparation containing bisoprolol |
EP1932523A1 (en) * | 2005-09-09 | 2008-06-18 | Nitto Denko Corporation | Adhesive preparation containing bisoprolol |
WO2007035939A2 (en) * | 2005-09-23 | 2007-03-29 | Alza Corporation | High enhancer-loading polyacrylate formulation for transdermal applications |
WO2007065303A1 (en) * | 2005-12-09 | 2007-06-14 | Beijing Kangbeide Pharmaceutical Technology Development Co., Ltd. | Transdermal patch containing isosorbide dinitrate and bisoprolol |
US20080292685A1 (en) * | 2005-12-09 | 2008-11-27 | Beijing Kangbeide Pharmaceutical Technology Development Co., Ltd | Transdermal Patch Containing Isosorbide Dinitrate and Bisoprolol |
Also Published As
Publication number | Publication date |
---|---|
WO2009026133A2 (en) | 2009-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006041908A3 (en) | Transdermal delivery of estradiol | |
WO2008123625A1 (en) | Method for activating receptor by cofactor and method for utilizing ligand activity | |
HK1103393A1 (en) | Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes | |
WO2006050221A3 (en) | Porous photonic crystals for drug delivery to the eye | |
HK1134041A1 (en) | Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same | |
WO2011076621A3 (en) | Transdermal therapeutic system for administering rivastigmine or derivatives thereof | |
EP2029292A4 (en) | Infused sponge delivery system | |
WO2006047362A3 (en) | Transdermal delivery systems | |
WO2006044206A3 (en) | Transdermal drug delivery device including an occlusive backing | |
WO2011079001A3 (en) | Anhydrous liquid antiperspirant/deodorant composition | |
WO2007094940A3 (en) | Implantable medical device with surface-eroding polyester drug delivery coating | |
IL181516A0 (en) | Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery | |
WO2008078318A3 (en) | Systems and devices for sustained delivery of therapeutic fluid | |
WO2006041907A3 (en) | Transdermal delivery of estradiol | |
AU2003221770A1 (en) | Controlled release transdermal drug delivery | |
WO2009026135A3 (en) | Controlled transdermal bisoprolol delivery system | |
WO2009032737A3 (en) | Systems and methods for delivering medication | |
LT2529732T (en) | Transdermal therapeutic system with an adhesive layer, method for siliconizing a backing layer of the system and use the use of the backing layer. | |
PL2259800T3 (en) | Use of 5-(2,6-di-morpholin-4-yl-pyrimidin-4-yl)-4-trifluoromethyl-pyridin-2-ylamine for the treatment of non small cell lung carcinoma with acquired resistance to epidermal growth factor receptor (EGFR) modulators. | |
EP2589379A4 (en) | Transdermal drug delivery system containing donepezil | |
AU2003215657A1 (en) | Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion. | |
WO2007092043A3 (en) | Bioactive material delivery systems comprising sol-gel compositions | |
WO2008156045A1 (en) | Management system for prescribing/preparing medicine which may cause severe side effect | |
WO2009144551A3 (en) | Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood | |
MY166972A (en) | Transdermal delivery system containing galantamine or salts thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08797954 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 07/06/2010) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08797954 Country of ref document: EP Kind code of ref document: A2 |